Viewing data from:

GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE

ANDA

DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN | A214781 | SUN PHARMACEUTICAL INDUSTRIES LTD

2 strengths0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-10-21 | 2 NDCs

Highest NADAC/Unit

$0.5451

per ea

Lowest NADAC/Unit

$0.3597

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
51660011054GUAIFENESIN-DM ER 1,200-60 MG	$0.5451	EA	Generic	—	2026-10-21
51660030141GUAIFENESIN-DM ER 600-30 MG TB	$0.3597	EA	Generic	—	2026-10-21

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain0 active DMFs1 inactive

0 active API suppliers hold Drug Master Files for this ingredient. Limited supplier base — potential supply chain risk.

DR REDDYS LABORATORIES LTDInactiveDEXTROMETHORPHAN, USP

DMF 155612001

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (2)

Sort:

#001 — 30MG;600MG

0 patents0 exclusivities▴

TABLET, EXTENDED RELEASE;ORAL | Approved: Jul 1, 2021

No patent or exclusivity listings for this strength.

#002 — 60MG;1.2GM

0 patents0 exclusivities▾

TABLET, EXTENDED RELEASE;ORAL | Approved: Jul 1, 2021